Overview
- 62 inspections across 59 sites are on record.
- 245 Form 483 observations are attributed to this investigator.
- Most recent recorded activity is 2026-02-17.
About Massoud Motamed
Massoud Motamed is an FDA investigator with 62 inspections at 59 sites and 245 Form 483 observations on record since April 2015, most recently in Livingston, United Kingdom in February 2026. The published record holds 24 of the resulting Form 483s, issued between April 2015 and June 2017.
Those 24 forms are long: 9.1 observations on average, against an industry median of three. The longest, 36 observations, went to Allergan Sales in Waco, Texas in October 2016. Others include Mylan Pharmaceuticals in Morgantown (10), I.V. Specialty in Austin (18), Talon Compounding Pharmacy in San Antonio (13) and Temmentech in Switzerland (12). Foreign inspections include Fresenius Kabi Austria in Graz, ILS in Derby, UK, and three Indian facilities: Mylan Laboratories in Nashik, QbD Research in Thane and Doctors' Analytical Laboratories in Navi Mumbai.
Sterile and compounding operations are a recurring thread, with US Compounding in Conway inspected twice and Cantrell Drug Company in Little Rock. The section cited most is 21 CFR 211.192, investigations of discrepancies and failures, on seven of the 12 forms with structured citations, followed by 211.113(b) aseptic process validation and the 211.42(c)(10) aseptic area requirements. For what a 483 is and what follows one, see what an FDA Form 483 is.
At a glance
Inspections
62
Sites
59
Observations
245
Career since
Apr 2015
Form 483s on record
Every Form 483 in the published record that names Massoud Motamed, most recent first.
| Issued | Company and facility | Category | Observations |
|---|---|---|---|
| 29 Jun 2017 | Cantrell Drug CompanyLittle Rock, United States | Human Drugs | 8 |
| 17 Mar 2017 | Fresenius Kabi AustriaGraz, Austria | Human Drugs | 6 |
| 7 Mar 2017 | ILS LimitedDerby, United Kingdom | Human Drugs | 4 |
| 12 Jan 2017 | FUJIFILM Ultra Pure Solutions, IncCarrollton, United States | Human Drugs | 4 |
| 18 Nov 2016 | Mylan Pharmaceuticals IncMorgantown, United States | Human Drugs | 10 |
| 28 Oct 2016 | Allergan Sales, LLCWaco, United States | Human Drugs | 36 |
| 14 Sep 2016 | Mylan Laboratories LimitedNasik, Nashik, India | Human Drugs | 6 |
| 15 Jul 2016 | US Compounding IncConway, United States | Human Drugs | 6 |
| 17 Jun 2016 | Temmentech AGSumiswald, Switzerland | Human Drugs | 12 |
| 16 Mar 2016 | Wellmark International dba Central Life SciencesDallas, United States | Animal Drugs & Feeds | 4 |
| 29 Feb 2016 | QbD Research and Development Lab Pvt. Ltd.Thane, India | Human Drugs | 9 |
| 24 Feb 2016 | Doctors' Analytical Laboratories Private LimitedNavi Mumbai, India | Human Drugs | 6 |
| 5 Feb 2016 | I.V. Specialty, LtdAustin, United States | Human Drugs | 18 |
| 20 Nov 2015 | Nippon Sanso Matheson, Inc.Dallas, United States | Human Drugs | 4 |
| 17 Nov 2015 | Mary Kay, IncDallas, United States | Human Drugs | 10 |
| 22 Oct 2015 | L & M Pharmaceuticals, Inc.Redfield, United States | Animal Drugs & Feeds | 10 |
| 21 Oct 2015 | Tribute LabsConway, United States | Human Drugs | 7 |
| 8 Oct 2015 | Goodier Cosmetics LLCDallas, United States | Human Drugs | 10 |
| 21 Aug 2015 | US Compounding IncConway, United States | Human Drugs | 10 |
| 24 Jun 2015 | Talon Compounding PharmacySan Antonio, United States | Human Drugs | 13 |
| 10 Jun 2015 | Blount Fine Foods, Inc.Mckinney, United States | Foods & Cosmetics | 8 |
| 3 Jun 2015 | America's Beverage CompanyIrving, United States | Foods & Cosmetics | 2 |
| 10 Apr 2015 | Target DC T3897Denton, United States | Foods & Cosmetics | 5 |
| 1 Apr 2015 | B & P Industrial Inc.Tulsa, United States | Human Drugs | 10 |
Regulations cited most
How many of Massoud Motamed's Form 483s cite each section of the Code of Federal Regulations.
| Regulation | What it covers | Form 483s citing it |
|---|---|---|
| 21 CFR 211.192 | Production record review and investigation of discrepancies | 7 |
| 21 CFR 211.113(b) | Control of microbiological contamination | 4 |
| 21 CFR 211.160(b) | Laboratory controls, general requirements | 3 |
| 21 CFR 211.42(c)(10)(iv) | Design and construction of facilities, including aseptic processing areas | 3 |
| 21 CFR 211.165(e) | Testing and release for distribution | 2 |
| 21 CFR 211.22(a) | Responsibilities of the quality control unit | 2 |
| 21 CFR 211.110(a) | Sampling and testing of in-process materials | 2 |
| 21 CFR 211.42(c)(10)(vi) | Design and construction of facilities, including aseptic processing areas | 2 |
Recent inspections
Most recent inspections in the published record.
| Site | Date | Category | Form 483 |
|---|---|---|---|
| Valneva Scotland Ltd. | 17 Feb 2026 | Biologics | On file |
| Serum Institute of India Private Ltd. | 30 Jan 2026 | Biologics | On file |
| Genzyme Ireland Limited | 20 Jan 2026 | Biologics | On file |
| Genzyme Flanders | 7 Nov 2025 | Biologics | On file |
| Celgene Corporation | 18 Jul 2025 | Biologics | On file |
Sites inspected
Co-investigators
Investigators who co-signed a Form 483 with Massoud Motamed.
- Latorie S Jones2 shared 483s
- Scott T Ballard2 shared 483s
- Shelby N Marler2 shared 483s
- Matthew R Maddox2 shared 483s
- Karlton T Watson2 shared 483s
- Haijing Hu1 shared 483
- Pratik S Upadhyay1 shared 483
- Atul Agrawal1 shared 483
- Chaltu N Wakijra1 shared 483
- Ademola O Daramola1 shared 483
- Angela Mock1 shared 483
- Lloyd D Payne1 shared 483
- Unnee Ranjan1 shared 483
- Darla J Christopher1 shared 483
- Christopher L Jacobs1 shared 483
- Dana M Lewis1 shared 483
- Crystal S Harris-Smith1 shared 483
- Crystal S Harris1 shared 483
- Saleem A Akhtar1 shared 483
- Jogy George1 shared 483
Full investigator report
Get the verbatim findings behind Massoud Motamed's 245 observations
Source 483 PDFs, verbatim observations, and how each site responded, so your team knows what they cite before they arrive.
- New inspections and Form 483s, mapped to the CFR citation
- Warning letter outcomes, and the citation patterns they repeat
- Their co-investigators, so no surprises about who shows up on site